Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
NIH
Research
NIH leader's research misconduct calls drugs into question
One of the drugs facing new questions is prasinezumab, an antibody for Parkinson’s disease being developed by Prothena Biosciences and Roche.
Darren Incorvaia
Sep 26, 2024 9:12am
Hibernating squirrels hold protein that clears cataracts: study
Sep 20, 2024 11:58am
FDA clears its first fingerstick hepatitis C diagnostic test
Jul 2, 2024 11:04am
NIAID is 'on the ball' with bird flu research, but gaps remain
Jun 10, 2024 5:50am
NIH pairs primary care with research in $30M program
Jun 10, 2024 4:30am
Joe Biden reportedly chooses NIH head—Chutes & Ladders
Apr 21, 2023 9:30am